1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
186.84 USD   -3.78%
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/05U.S. administers over 7,300 Novavax vaccine doses - CDC
RE
08/04Goldman Sachs Raises Moderna's Price Target to $296 From $290, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SVB Securities Adjusts Moderna's Price Target to $70 From $80, Keeps Underperform Rating

06/07/2022 | 08:47am EDT


© MT Newswires 2022
All news about MODERNA, INC.
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/05U.S. administers over 7,300 Novavax vaccine doses - CDC
RE
08/04Goldman Sachs Raises Moderna's Price Target to $296 From $290, Maintains Buy Rating
MT
08/04Morgan Stanley Adjusts Moderna's Price Target to $197 From $199, Maintains Equalweight ..
MT
08/04SVB Securities Adjusts Moderna's Price Target to $74 from $77, Keeps Underperform Ratin..
MT
08/04MARKETSCREENER'S WORLD PRESS REVIEW : August 4, 2022
MS
08/04Moderna Reiterates $21 Billion COVID-19 Vaccine Sales Forecast On Expected New Approval..
MT
08/03US Stocks Advance on Surprise Increase in Service Activity, Rise in Factory Orders
MT
08/03Nasdaq ends at three-month high as PayPal fuels optimism
RE
08/03MODERNA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 875 M - -
Net income 2022 11 063 M - -
Net cash 2022 17 049 M - -
P/E ratio 2022 7,03x
Yield 2022 -
Capitalization 73 092 M 73 092 M -
EV / Sales 2022 2,56x
EV / Sales 2023 5,16x
Nbr of Employees 2 700
Free-Float 92,1%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 186,84 $
Average target price 214,00 $
Spread / Average Target 14,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.80%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235
CELLTRION, INC.-0.51%20 815